216 related articles for article (PubMed ID: 36367657)
1. Protein Expression of Amino Acid Transporters Is Altered in Isolated Cerebral Microvessels of 5xFAD Mouse Model of Alzheimer's Disease.
Puris E; Saveleva L; de Sousa Maciel I; Kanninen KM; Auriola S; Fricker G
Mol Neurobiol; 2023 Feb; 60(2):732-748. PubMed ID: 36367657
[TBL] [Abstract][Full Text] [Related]
2. Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model.
Puris E; Auriola S; Petralla S; Hartman R; Gynther M; de Lange ECM; Fricker G
Neurobiol Dis; 2022 Jul; 169():105741. PubMed ID: 35472634
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease.
Puris E; Saveleva L; Auriola S; Gynther M; Kanninen KM; Fricker G
Front Pharmacol; 2024; 15():1365051. PubMed ID: 38572427
[TBL] [Abstract][Full Text] [Related]
4. Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model.
Puris E; Auriola S; Korhonen P; Loppi S; Kanninen KM; Malm T; Koistinaho J; Gynther M
J Pharm Sci; 2021 Dec; 110(12):3953-3962. PubMed ID: 34403652
[TBL] [Abstract][Full Text] [Related]
5. Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
Uras I; Karayel-Basar M; Sahin B; Baykal AT
Alzheimers Dement; 2023 Oct; 19(10):4572-4589. PubMed ID: 36934297
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.
Shawahna R; Uchida Y; Declèves X; Ohtsuki S; Yousif S; Dauchy S; Jacob A; Chassoux F; Daumas-Duport C; Couraud PO; Terasaki T; Scherrmann JM
Mol Pharm; 2011 Aug; 8(4):1332-41. PubMed ID: 21707071
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients.
Al-Majdoub ZM; Al Feteisi H; Achour B; Warwood S; Neuhoff S; Rostami-Hodjegan A; Barber J
Mol Pharm; 2019 Mar; 16(3):1220-1233. PubMed ID: 30735053
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
9. Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
Boyanova ST; Lloyd-Morris E; Corpe C; Rahman KM; Farag DB; Page LK; Wang H; Fleckney AL; Gatt A; Troakes C; Vizcay-Barrena G; Fleck R; Reeves SJ; Thomas SA
PLoS One; 2023; 18(10):e0286278. PubMed ID: 37874822
[TBL] [Abstract][Full Text] [Related]
10. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer's Disease Is Associated with Activation of HIF-1 Signaling Pathway.
Petralla S; Saveleva L; Kanninen KM; Oster JS; Panayotova M; Fricker G; Puris E
Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38296900
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer's Disease.
Milanovic D; Petrovic S; Brkic M; Avramovic V; Perovic M; Ivkovic S; Glibetic M; Kanazir S
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200627
[TBL] [Abstract][Full Text] [Related]
13. Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer's Disease and the Clinical Significance.
Jia Y; Wang N; Zhang Y; Xue D; Lou H; Liu X
Aging Dis; 2020 Apr; 11(2):390-404. PubMed ID: 32257549
[TBL] [Abstract][Full Text] [Related]
14. Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
Gurel B; Cansev M; Sevinc C; Kelestemur S; Ocalan B; Cakir A; Aydin S; Kahveci N; Ozansoy M; Taskapilioglu O; Ulus IH; Başar MK; Sahin B; Tuzuner MB; Baykal AT
J Alzheimers Dis; 2018; 61(4):1399-1410. PubMed ID: 29376847
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL
mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884
[TBL] [Abstract][Full Text] [Related]
16. Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease.
Vorobyov V; Bakharev B; Medvinskaya N; Nesterova I; Samokhin A; Deev A; Tatarnikova O; Ustyugov AA; Sengpiel F; Bobkova N
J Alzheimers Dis; 2019; 70(1):241-256. PubMed ID: 31177214
[TBL] [Abstract][Full Text] [Related]
17. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5XFAD mice, an animal model of Alzheimer's disease.
Moon M; Jeong I; Kim CH; Kim J; Lee PK; Mook-Jung I; Leblanc P; Kim KS
J Neurochem; 2015 Jan; 132(2):254-62. PubMed ID: 25156412
[TBL] [Abstract][Full Text] [Related]
18. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
[TBL] [Abstract][Full Text] [Related]
20. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
